These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7890010)

  • 1. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.
    van der Mooren MJ; Wouters MG; Blom HJ; Schellekens LA; Eskes TK; Rolland R
    Eur J Clin Invest; 1994 Nov; 24(11):733-6. PubMed ID: 7890010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.
    van der Mooren MJ; Demacker PN; Thomas CM; Borm GF; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(2):117-23. PubMed ID: 8157140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.
    Mijatovic V; Kenemans P; Netelenbos C; Jakobs C; Popp-Snijders C; Peters-Muller ER; van der Mooren MJ
    Fertil Steril; 1998 May; 69(5):876-82. PubMed ID: 9591496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.
    Mijatovic V; Kenemans P; Jakobs C; van Baal WM; Peters-Muller ER; van der Mooren MJ
    Obstet Gynecol; 1998 Mar; 91(3):432-6. PubMed ID: 9491873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women.
    Smolders RG; de Meer K; Kenemans P; Teerlink T; Jakobs C; van der Mooren MJ
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):55-9. PubMed ID: 15474245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
    Godsland IF; Manassiev NA; Felton CV; Proudler AJ; Crook D; Whitehead MI; Stevenson JC
    Clin Endocrinol (Oxf); 2004 May; 60(5):541-9. PubMed ID: 15104556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
    van der Mooren MJ; Demacker PN; Thomas CM; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):153-60. PubMed ID: 1459329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
    Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.
    Gaspard UJ; Wery OJ; Scheen AJ; Jaminet C; Lefebvre PJ
    Climacteric; 1999 Jun; 2(2):93-100. PubMed ID: 11910673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
    Bukowska H; Stanosz S; Zochowska E; Millo B; Sieja K; Chełstowski K; Naruszewicz M
    Metabolism; 2005 Jan; 54(1):72-8. PubMed ID: 15562383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
    Foster RH; Balfour JA
    Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol.
    Burch DJ; Spowart KJ; Jesinger DK; Randall S; Smith SK
    Br J Obstet Gynaecol; 1995 Mar; 102(3):243-8. PubMed ID: 7794851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
    van Baal WM; Kenemans P; Stehouwer CD; Peters-Muller ER; van Vugt JM; van der Mooren MJ
    Am J Obstet Gynecol; 1999 Dec; 181(6):1365-73. PubMed ID: 10601914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective study.
    van der Mooren MJ; Hanselaar AG; Borm GF; Rolland R
    Maturitas; 1994 Dec; 20(2-3):175-80. PubMed ID: 7715470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women.
    Berger PB; Herrmann RR; Dumesic DA
    Mayo Clin Proc; 2000 Jan; 75(1):18-23. PubMed ID: 10630752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
    Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal WM; Visser CA; van der Mooren MJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Kaleli B; Yildirim B; Demir S; Alatas E
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.
    Mijatovic V; Kenemans P; Netelenbos JC; Peters-Muller ER; van Kamp GJ; Voetberg GA; van de Weijer PH; van der Mooren MJ
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3543-7. PubMed ID: 9360504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine in women's health.
    Lobo RA
    Menopause; 2003; 10(4):271-3. PubMed ID: 12851508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.